Drug Trial Radar · NCT05528172
A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery
Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
330
Actual
Start
Aug 4, 2022
Primary completion
Jun 22, 2023
Study completion Jun 22, 2023
Sponsor
- Lead sponsor
- Kowa Research Institute, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 6, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and efficacy of K-321 in subjects after cataract surgery
Conditions
- Corneal Edema After Cataract Surgery
Interventions
RipasudilDrug
K-321 ophthalmic solution
PlaceboDrug
Placebo ophthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Central Corneal Endothelial Cell Density (ECD) at Week 12Time frame: Baseline to Week 12
Locations
45 sites in 2 countries. Site status is shown where the registry gives one.
Cornea and Cataract Consultants of Arizona
Phoenix, Arizona
Schwartz Laser Eye Center
Scottsdale, Arizona
Inland Eye Specialists
Hemet, California
United Medical Research Institute
Inglewood, California
Alvarado Eye Associates
La Mesa, California
SoCal Eye Physicians and Associates
Long Beach, California
Visionary Research Institute
Newport Beach, California
Pendleton Eye Center
Oceanside, California
North Bay Eye Associates
Petaluma, California
Martel Eye Medical Group
Rancho Cordova, California
Premiere Practice Management, LLC
Torrance, California
Wolstan and Goldberg Eye Associates
Torrance, California
Icon Eye Care
Grand Junction, Colorado
Eye Associates of Fort Myers
Fort Myers, Florida
Levenson Eye Associates
Jacksonville, Florida
International Research Center
Tampa, Florida
Clayton Eye Clinical Research, LLC
Morrow, Georgia
Durrie Vision
Overland Park, Kansas
Eye Care Institute/Butchertown Clinical Trials
Louisville, Kentucky
Maine Eye Center
Portland, Maine
Fraser Eye Care Center
Fraser, Michigan
Silverstein Eye Centers
Kansas City, Missouri
Tekwani Vision Center
St Louis, Missouri
Ophthalmology Associates
St Louis, Missouri
Ophthalmology Consultantants, Ltd.
St Louis, Missouri
Comprehensive Eye Care, Ltd.
Washington, Missouri
Vance Thompson Vision-MT
Bozeman, Montana
Vance Thompson Vision- NE
Omaha, Nebraska
Wellish Vision Institute
Las Vegas, Nevada
Center for Sight
Las Vegas, Nevada
NYU Grossman School of Medicine
New York, New York
Seeta Eye Center
Poughkeepsie, New York
Vance Thompson Vision ND
West Fargo, North Dakota
Cincinnati Eye Institute
Cincinnati, Ohio
Cincinnati Eye Institute
Mason, Ohio
Eye Care Specialists
Kingston, Pennsylvania
Vance Thompson Vision
Sioux Falls, South Dakota
Keystone Research
Austin, Texas
Hill Country Eye Center
Cedar Park, Texas
Louis M. Alpern, M.D., M.P.H.,P.A.
El Paso, Texas
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.